02 Apr 2024 FY23 revenue was up by 9.3%
CROSBY Research – China Suntien Green Energy (956 HK/BUY): Increasing capex in FY24
CROSBY Research – Anta Sports (2020 HK/BUY): FY23 NP up by 35% YoY, better than expected
28 Mar 2024 Anta’s FY23 revenue was up b
CROSBY Research – Canvest Environmental (1381 HK/BUY): Topline down 40% on fewer construction projects
27 Mar 2024 FY23 revenue decreased by 39
CROSBY Research – Natural Food International (1837 HK/BUY): Better than expected FY23 results
27 Mar 2024 NFI’s FY23 topline was up by
CROSBY Research – Q-Tech (1478 HK/BUY): Revenue growth turned around and GPM bottomed out in 2H23; expect product mix improvement persist into FY24
27 Mar 2024 After three consecutive decl
CROSBY Research – WL Delicious (9985 HK): Expects a >15% YoY sales growth in FY24
25 Mar 2024 WL Delicious ‘s FY23 revenue
CROSBY Research – Crosby Bi-noculars (Bi-weekly Issue 55)
25 Mar 2024 According to Reuters, China
CROSBY Research – Sunny Optical (2382 HK/BUY): Conservative HLS/ HCM shipment and GPM guidance, but product mix improvement may be upside surprise
25 Mar 2024 After four consecutive decli
CROSBY Research – Tai Hing (6811 HK): Turnaround in FY23 with a generous payout ratio
25 Mar 2024 Tai Hing’s FY23 revenue incr
CROSBY Research – Vincent Medical (1612 HK/BUY): Achieving financial turnaround in FY23
21 Mar 2024 Vincent Medical’s FY23 turno